A first-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and safety in skin cancer patients

by Miko Yamada, Dennis M. Miller, Melinda Lowe, Casey Rowe, Dominic Wood, H. Peter Soyer, Kelly Byrnes-Blake, Julia Parrish-Novak, Laura Ishak, James M. Olson, Gordon Brandt, Paul Griffin, Lynda Spelman, Tarl W. Prow
Published 2021-09-01